Consent for Breast and Prostate CancerTreatment
Provider Type
- Physicians and Practitioners
- Participating Physician Groups (PPG)
- Hospitals
- Ancillary
Breast Cancer Treatment Information and Consent Requirements
Health and Safety Code 109275 requires primary care physicians to provide a summary discussing alternative breast cancer treatments and their risks and benefits to women upon diagnosis of breast cancer. The National Cancer Institute provides a wealth of information for consumers to learn about breast cancer and treatment options. Links are also available from the Medical Board of California. .
- Breast Cancer Treatment
- Male Brest Cancer Treatment
- Breast Cancer During Pregnancy
The summary does not supplant the physician's duty to obtain the member's informed consent. In addition to providing a standardized summary, physicians should discuss the risks, benefits and possible alternatives to any planned procedures with the member and document the discussion in the medical record.
Prostate Cancer Treatment Information to Members
Providers are required to tell members receiving a digital rectal exam that a prostate-specific antigen (PSA) test is available for prostate cancer detection.
The National Cancer Institute provides information about the detection, symptoms, diagnosis, and treatment of prostate cancer on their website.
The Prostate Cancer Foundation Prostate Cancer Patient Guides provides information to patients on prostate cancer treatment options, and are available at The Prostate Cancer Foundation’s website. This booklet must be given by physicians upon examination of the prostate gland, to certain patients as specified by The Medical Board of California.